COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS WITH RELAPSED/REFRACTORY NON‐HODGKIN LYMPHOMA RECEIVING CAR T CELLS VERSUS BISPECIFIC ANTIBODIES | Publicación